https://de.marketscreener.com/kurs/aktie/KURA-ONCOLOGY-INC-24827079/news/Kura-Oncology-Inc-meldet-positive-vorlaufige-Daten-zur-Ziftomenib-Kombination-bei-akuter-myeloisc-45842836/?utm_source=telegram&utm_medium=social&utm_campaign=share